Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Flexion Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Flexion Therapeutics Inc.

Dentsply Sirona Declares Quarterly Cash Dividend

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Dentsply Sirona

TearLab Provides Updates on Its Osmolarity Test and TearLab Discovery™ Platform

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  TearLab Corporation

ERLEADA(TM) (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Granted U.S. FDA Approval for the Treatment of Patients with Non-Metastatic Castration-Resistant Prostate Cancer

HORSHAM, Pa., Feb. 14, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved ERLEADA(TM) (apalutamide), a next-generation androgen receptor inhibitor,(1) for the treatment of patients with... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab)

THOUSAND OAKS, Calif., Feb. 14, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data supporting the BLINCYTO(® )(blinatumomab) supplemental Biologics License Application (sBLA) for... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Amgen, Inc.

Neurocrine Biosciences Will File New Drug Application for Opicapone for Parkinson's Disease Based on Existing Pivotal Clinical Trial Data

SAN DIEGO, Feb. 14, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, today announced that the U.S. Food and Drug Administration (FDA) has provided guidance on the regulatory path forward to support... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Neurocrine Biosciences, Inc.

Vanda Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results

WASHINGTON, Feb. 14, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended December 31, 2017.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Vanda Pharmaceuticals

Financial Education Benefits Center Reveals New Medical Imaging Benefit

SAN RAMON, Calif., Feb. 14, 2018 /PRNewswire/ -- Whether trying to diagnose an illness or monitoring a known problem, medical imaging is a key tool in modern healthcare. While experts warn against excessive... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

CTI BioPharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference

SEATTLE, Feb. 14, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will present at the 7(th) Annual Leerink Partners Global Healthcare Conference in New York, NY on Thursday, February 15, 2018 at 2:30 PM ET and host one-on-one meetings.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  CTI BioPharma Corp.

Veloxis Secures $60M in Debt Financing

CARY, N.C., Feb. 14, 2018 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), a specialty pharmaceutical company committed to improving the lives of transplant patients, today announced that it has obtained $60... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Veloxis Pharmaceuticals Inc.

Convaid R82 to Debut Convaid Flyer, a Growth-adjustable, Tilt-in-Space Pediatric Wheelchair at Abilities Expo Los Angeles

TORRANCE, Calif., Feb. 14, 2018 /PRNewswire-iReach/ -- Next weekend marks the first Abilities Expo of 2018, to be held at the Los Angeles Convention Center from Friday, February 23 through Sunday, February 25th where Convaid... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Convaid, Inc.

DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2018 Financial Results

VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 14, 2018 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new cancer... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Hallwang Clinic - Kate Winslet and Leonardo DiCaprio Saved a Young Mum's Life

DORNSTETTEN, Germany, February 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Global Intravenous (IV) Iron Drugs Market 2012-2022 by Value, Therapeutic Application & Product Type

DUBLIN, Feb. 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Science self-corrects: cancer gene does not pass reproducibility test

COLD SPRING HARBOR, N.Y., Feb. 14, 2018 /PRNewswire/ -- A decade ago, several labs discovered that a gene called MELK is overexpressed, or turned on to a high degree, in many cancer cell types. This prompted multiple ongoing clinical trials to test whether drugs that inhibit MELK can treat cancer... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Cannabis Companies that Could Present Endless Opportunities for Investors

LAS VEGAS, February 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Dr. James A. Simon Becomes President of The International Society for the Study of Women's Sexual Health (ISSWSH)

BURNSVILLE, Minn., Feb. 14, 2018 /PRNewswire/ -- The International Society for the Study of Women's Sexual Health (ISSWSH.org), the preeminent organization focusing on the biopsychosocial aspects of women's sexuality, welcomes... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Doctor Evidence collaborated on the underlying systematic review for new guideline published by leading oncology association

SANTA MONICA, Calif., Feb. 14, 2018 /PRNewswire/ -- Doctor Evidence (DRE), a global health technology and data company, is proud to have performed the systematic review of evidence, through the GROWTH program, in support of a new guideline issued by the American Society of Clinical Oncology,... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Two Day Method Development and Validation for Assays Supporting Testing of Biologics Seminar (Orlando, FL, United States - March 22-23, 2018)

DUBLIN, Feb. 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Two Day Pharma Compliace Seminar: Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical  (Burlingame CA, United States - March 22nd-23rd, 2018)

DUBLIN, Feb. 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑